These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2571213)

  • 1. Permanent brain damage and pertussis vaccination: is the end of the saga in sight?
    Griffith AH
    Vaccine; 1989 Jun; 7(3):199-210. PubMed ID: 2571213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCES reconsidered: summary of a 1989 workshop. National Childhood Encephalopathy Study.
    Marcuse EK; Wentz KR
    Vaccine; 1990 Dec; 8(6):531-5. PubMed ID: 1982384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study.
    Cherry JD
    Curr Probl Pediatr; 1984 Feb; 14(2):1-78. PubMed ID: 6368134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whooping cough and pertussis vaccine: a comparison of risks and benefits in Britain during the period 1968-83.
    Stewart GT
    Dev Biol Stand; 1985; 61():395-405. PubMed ID: 3835080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute encephalopathy and chronic neurological damage after pertussis vaccine.
    Cowan LD; Griffin MR; Howson CP; Katz M; Johnston RB; Shaywitz BA; Fineberg HV
    Vaccine; 1993 Nov; 11(14):1371-9. PubMed ID: 7906066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neurologist looks at neurological disease temporally related to DTP immunization.
    Stephenson JB
    Tokai J Exp Clin Med; 1988; 13 Suppl():157-64. PubMed ID: 3078804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children.
    Miller D; Wadsworth J; Diamond J; Ross E
    Dev Biol Stand; 1985; 61():389-94. PubMed ID: 3879684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age at pertussis immunization as it relates to current epidemiology and disease control.
    Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis vaccination.
    Prensky AL
    Dev Med Child Neurol; 1974 Aug; 16(4):539-43. PubMed ID: 4152994
    [No Abstract]   [Full Text] [Related]  

  • 14. Workshop on neurologic complications of pertussis and pertussis vaccination.
    Menkes JH; Kinsbourne M
    Neuropediatrics; 1990 Nov; 21(4):171-6. PubMed ID: 1981251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results with a new DTP vaccine in Japan.
    Kimura M; Hikino N
    Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study.
    Gale JL; Thapa PB; Wassilak SG; Bobo JK; Mendelman PM; Foy HM
    JAMA; 1994 Jan; 271(1):37-41. PubMed ID: 7903109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes of Victorian vaccine providers to pertussis vaccine.
    MacIntyre CR; Nolan T
    Med J Aust; 1994 Sep; 161(5):295-9. PubMed ID: 7830663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis and pertussis vaccine: further analysis of benefits, risks and costs.
    Hinman AR; Koplan JP
    Dev Biol Stand; 1985; 61():429-37. PubMed ID: 3938968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.
    Barlow WE; Davis RL; Glasser JW; Rhodes PH; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Ward JI; Marcy SM; DeStefano F; Chen RT; Immanuel V; Pearson JA; Vadheim CM; Rebolledo V; Christakis D; Benson PJ; Lewis N;
    N Engl J Med; 2001 Aug; 345(9):656-61. PubMed ID: 11547719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.